Summary

Persistence Market Research has recently released an extensive report on the global market for whole exome sequencing (WES). This report provides a comprehensive analysis of essential market dynamics, including key drivers, trends, opportunities, and challenges, offering in-depth insights into the market structure. The publication presents exclusive data and projections regarding the growth trajectory of the global whole exome sequencing market from 2025 to 2032.

Key Insights:

•Whole Exome Sequencing Market Size (2025E): USD 2,173.5 Million
•Projected Market Value (2032F): USD 6,879.6 Million
•Global Market Growth Rate (CAGR 2025 to 2032): 17.9%

Whole Exome Sequencing Market - Report Scope:

Whole exome sequencing is a critical technology used for exploring genetic disorders, offering vital insights into disease mechanisms and potential therapeutic interventions. The market caters to hospitals, research institutions, academic laboratories, and clinical settings, providing a range of sequencing services. The growth of the market is primarily fueled by advancements in sequencing technologies, decreasing costs, and increasing demand for precision medicine, genetic testing, and personalized healthcare.

Market Growth Drivers:

The whole exome sequencing market is being driven by several key factors, including the growing incidence of genetic diseases and the rising demand for personalized treatments. Advancements in sequencing technologies, such as next-generation sequencing (NGS), along with reduced sequencing costs, are also contributing to the expansion of the market. Moreover, the growing utilization of WES in cancer research, rare disease diagnosis, and drug development further promotes the widespread adoption of exome sequencing services. Additionally, government funding for genomic research and the expansion of genetic testing platforms present significant growth opportunities.

Market Restraints:

Despite promising growth, the whole exome sequencing market faces challenges related to the high costs of sequencing, data complexity, and regulatory issues. The difficulty in interpreting genetic data and the need for specialized expertise pose challenges for broader adoption, particularly in resource-constrained regions. Ethical concerns surrounding genetic testing, including data privacy and patient consent, continue to present hurdles. Furthermore, integrating genomic data into clinical practices remains a significant challenge, requiring collaboration across healthcare, regulatory, and research sectors.

Market Opportunities:

The whole exome sequencing market offers substantial growth opportunities through the integration of artificial intelligence (AI) for genomic data analysis, the increasing focus on rare genetic diseases, and a rising demand for precision medicine. Advances in portable and cost-effective sequencing devices are expected to drive new market prospects, particularly in point-of-care settings. Additionally, the expanding use of WES for companion diagnostics and targeted therapies is anticipated to fuel demand for sequencing services.

Key Questions Answered in the Report:

•What are the primary factors driving the growth of the whole exome sequencing market globally?
•How are advancements in sequencing technologies shaping the adoption of whole exome sequencing?
•What are the major applications of WES across healthcare and research settings?
•Who are the key players contributing to the whole exome sequencing market, and what strategies are they employing to maintain market relevance?
•What are the emerging trends and future prospects in the global whole exome sequencing market?

Competitive Intelligence and Business Strategy:

Leading companies in the global whole exome sequencing market, such as Illumina, Thermo Fisher Scientific, and Agilent Technologies, focus on innovation, product differentiation, and strategic partnerships to stay ahead in the competitive landscape. These companies are heavily investing in research and development to advance sequencing technology, enhance accuracy, and reduce sequencing costs. Partnerships with academic institutions, healthcare providers, and biotechnology firms help to expand market access and encourage the adoption of WES technologies. Furthermore, the emphasis on personalized medicine and targeted therapies continues to drive research and investment in the WES sector.

Key Companies Profiled:

•CD Genomics
•Eurofins Genomics
•GENEWIZ (Azenta Life Sciences)
•Illumina, Inc.
•Integrated DNA Technologies, Inc.
•Blueprint Genetics Oy
•Caris Life Sciences
•MedGenome
•Psomagen
•3billion, Inc.
•BGI
•Mapmygenome
•Almac Group
•CeGaT GmbH
•Novogene Co., Ltd
•ONEOMICS
•Celemics, Inc.
•Dreamgenics, S.L.
•Gene by Gene, Ltd
•VERITAS INTERCONTINENTAL
•Laboratory Corporation of America® Holdings
•Revvity
•Thermo Fisher Scientific Inc.

Whole Exome Sequencing Market Research Segmentation:

The whole exome sequencing market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various healthcare needs and research fields.

By Product:

•Instruments
•Consumables
•Software and Services

By Application:

•Drug Discovery & Development
•Clinical Diagnostics
•Personalized Medicines
•Others

By Technology:

•ION Semiconductor Sequencing
•Sequencing by Synthesis
•Others

By End-User:

•Hospitals & Diagnostic Laboratories
•Pharma & Biotech Companies
•Contract Research Organizations (CROs)
•Academic and Research Institutes
•Others

By Region:

•North America
•Europe
•East Asia
•South Asia and Oceania
•Latin America
•Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Whole Exome Sequencing Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Porter’s Five Forces Analysis
3.4. PESTLE Analysis
3.5. Promotional Strategies, By Key Players
4. Price Analysis, 2025A
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Whole Exome Sequencing Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
5.2.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
5.3. Global Whole Exome Sequencing Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
5.3.3.1. Instruments
5.3.3.2. Consumables
5.3.3.3. Software & Services
5.3.4. Market Attractiveness Analysis: Product
5.4. Global Whole Exome Sequencing Market Outlook: Application
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Mn), By Application, 2019-2024
5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
5.4.3.1. Drug Discovery & Development
5.4.3.2. Clinical Diagnostics
5.4.3.3. Personalized Medicines
5.4.3.4. Others
5.4.4. Market Attractiveness Analysis: Application
5.5. Global Whole Exome Sequencing Market Outlook: Technology
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn), By Technology, 2019-2024
5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
5.5.3.1. ION Semiconductor Sequencing
5.5.3.2. Sequencing by Synthesis
5.5.3.3. Others
5.5.4. Market Attractiveness Analysis: Technology
5.6. Global Whole Exome Sequencing Market Outlook: End User
5.6.1. Introduction / Key Findings
5.6.2. Historical Market Size (US$ Mn), By End User, 2019-2024
5.6.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
5.6.3.1. Hospitals & Diagnostic Laboratories
5.6.3.2. Pharma & Biotech Companies
5.6.3.3. Contract Research Organizations (CROs)
5.6.3.4. Academic and Research Institutions
5.6.3.5. Others
5.6.4. Market Attractiveness Analysis: End User
6. Global Whole Exome Sequencing Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Whole Exome Sequencing Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Application
7.2.4. By Technology
7.2.5. By End User
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
7.4.1. Instruments
7.4.2. Consumables
7.4.3. Software & Services
7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
7.5.1. Drug Discovery & Development
7.5.2. Clinical Diagnostics
7.5.3. Personalized Medicines
7.5.4. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
7.6.1. ION Semiconductor Sequencing
7.6.2. Sequencing by Synthesis
7.6.3. Others
7.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
7.7.1. Hospitals & Diagnostic Laboratories
7.7.2. Pharma & Biotech Companies
7.7.3. Contract Research Organizations (CROs)
7.7.4. Academic and Research Institutions
7.7.5. Others
7.8. Market Attractiveness Analysis
8. Europe Whole Exome Sequencing Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Application
8.2.4. By Technology
8.2.5. By End User
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
8.4.1. Instruments
8.4.2. Consumables
8.4.3. Software & Services
8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
8.5.1. Drug Discovery & Development
8.5.2. Clinical Diagnostics
8.5.3. Personalized Medicines
8.5.4. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
8.6.1. ION Semiconductor Sequencing
8.6.2. Sequencing by Synthesis
8.6.3. Others
8.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
8.7.1. Hospitals & Diagnostic Laboratories
8.7.2. Pharma & Biotech Companies
8.7.3. Contract Research Organizations (CROs)
8.7.4. Academic and Research Institutions
8.7.5. Others
8.8. Market Attractiveness Analysis
9. East Asia Whole Exome Sequencing Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Application
9.2.4. By Technology
9.2.5. By End User
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
9.4.1. Instruments
9.4.2. Consumables
9.4.3. Software & Services
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
9.5.1. Drug Discovery & Development
9.5.2. Clinical Diagnostics
9.5.3. Personalized Medicines
9.5.4. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
9.6.1. ION Semiconductor Sequencing
9.6.2. Sequencing by Synthesis
9.6.3. Others
9.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
9.7.1. Hospitals & Diagnostic Laboratories
9.7.2. Pharma & Biotech Companies
9.7.3. Contract Research Organizations (CROs)
9.7.4. Academic and Research Institutions
9.7.5. Others
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Whole Exome Sequencing Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Application
10.2.4. By Technology
10.2.5. By End User
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
10.4.1. Instruments
10.4.2. Consumables
10.4.3. Software & Services
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
10.5.1. Drug Discovery & Development
10.5.2. Clinical Diagnostics
10.5.3. Personalized Medicines
10.5.4. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
10.6.1. ION Semiconductor Sequencing
10.6.2. Sequencing by Synthesis
10.6.3. Others
10.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
10.7.1. Hospitals & Diagnostic Laboratories
10.7.2. Pharma & Biotech Companies
10.7.3. Contract Research Organizations (CROs)
10.7.4. Academic and Research Institutions
10.7.5. Others
10.8. Market Attractiveness Analysis
11. Latin America Whole Exome Sequencing Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Application
11.2.4. By Technology
11.2.5. By End User
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
11.4.1. Instruments
11.4.2. Consumables
11.4.3. Software & Services
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
11.5.1. Drug Discovery & Development
11.5.2. Clinical Diagnostics
11.5.3. Personalized Medicines
11.5.4. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
11.6.1. ION Semiconductor Sequencing
11.6.2. Sequencing by Synthesis
11.6.3. Others
11.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
11.7.1. Hospitals & Diagnostic Laboratories
11.7.2. Pharma & Biotech Companies
11.7.3. Contract Research Organizations (CROs)
11.7.4. Academic and Research Institutions
11.7.5. Others
11.8. Market Attractiveness Analysis
12. Middle East & Africa Whole Exome Sequencing Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product
12.2.3. By Application
12.2.4. By Technology
12.2.5. By End User
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
12.4.1. Instruments
12.4.2. Consumables
12.4.3. Software & Services
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
12.5.1. Drug Discovery & Development
12.5.2. Clinical Diagnostics
12.5.3. Personalized Medicines
12.5.4. Others
12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
12.6.1. ION Semiconductor Sequencing
12.6.2. Sequencing by Synthesis
12.6.3. Others
12.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
12.7.1. Hospitals & Diagnostic Laboratories
12.7.2. Pharma & Biotech Companies
12.7.3. Contract Research Organizations (CROs)
12.7.4. Academic and Research Institutions
12.7.5. Others
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. CD Genomics
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Eurofins Genomics
13.3.3. GENEWIZ (Azenta Life Sciences)
13.3.4. Illumina, Inc.
13.3.5. Integrated DNA Technologies, Inc.
13.3.6. Blueprint Genetics Oy
13.3.7. Caris Life Sciences
13.3.8. MedGenome
13.3.9. Psomagen
13.3.10. 3billion, Inc.
13.3.11. BGI
13.3.12. Mapmygenome
13.3.13. Almac Group
13.3.14. CeGaT GmbH
13.3.15. Novogene Co., Ltd
13.3.16. ONEOMICS
13.3.17. Celemics, Inc.
13.3.18. Dreamgenics, S.L.
13.3.19. Gene by Gene, Ltd
13.3.20. VERITAS INTERCONTINENTAL
13.3.21. Laboratory Corporation of America® Holdings
13.3.22. Revvity
13.3.23. Thermo Fisher Scientific Inc.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations